Purpose: To evaluate the additional intraocular pressure lowering efficacy and safety of travoprost 0.004% compared with la-tanoprost 0.005%, in patients with open-angle glaucoma or ocular hypertension, whose intraocu...Purpose: To evaluate the additional intraocular pressure lowering efficacy and safety of travoprost 0.004% compared with la-tanoprost 0.005%, in patients with open-angle glaucoma or ocular hypertension, whose intraocular pressure was not adequately controlled on timolol 0.5% twice daily. Methods: A total of 30 patients with open-angle glaucoma or ocular hypertension were included in a six months, open-label, randomised study. All pa-展开更多
文摘Purpose: To evaluate the additional intraocular pressure lowering efficacy and safety of travoprost 0.004% compared with la-tanoprost 0.005%, in patients with open-angle glaucoma or ocular hypertension, whose intraocular pressure was not adequately controlled on timolol 0.5% twice daily. Methods: A total of 30 patients with open-angle glaucoma or ocular hypertension were included in a six months, open-label, randomised study. All pa-
